These 10 stocks you need to consider for a trading session
The stock market is expected to open in the red today as trends on the SGX Nifty point to the index opening negative in India.
The strong downward momentum on the stock market continued on Thursday. NSE Nifty lost 133 points to close at 17,764 while BSE Sensex fell 372 points to close at 59,636 points.
According to stock market experts, Nifty is now on the verge of support for the rising trendline linked by previous swing lows at 17,750 levels. This is not a good sign and signals the chance of a near-term break in trendline support to the downside.
Investors should watch out for the following stocks:
Trust branches: Reliance and Saudi Aramco have jointly decided that it would be beneficial for both parties to reassess the proposed investment in the O2C business given the changed context.
Sun Pharmaceutical Industry: The drug maker is recalling 1.10 lakh bottles of a generic drug for the treatment of erectile dysfunction in men on the US market due to a manufacturing defect.
Cadila Healthcare: Zydus Cadila has received final approval from the USFDA to market decitabine for injection at a strength of 50 mg / vial as a single-dose vial.
Bharti Airtel: The company increased the prepaid tariffs on November 26th.
Developer of the IRB infrastructure: The company announced that its shareholders have passed a resolution that will allow an inflow of Rs 5,347 billion into the company.
Vedanta: The company said the Supreme Court allowed the government to proceed with the proposal to openly sell all of its stake in Hindustan Zinc Ltd. Hindustan Zinc is a subsidiary of Vedanta Ltd.
Havells India: The company has started the commercial production of washing machines at its Ghiloth plant.
Biokon: Arohi Asset Management Pte Ltd acquired 0.108 percent of the shares in the company via an open market transaction and increased its stake from 4.963 percent to 5.071 percent.
Parsvnath Developer: Real estate firm Parsvnath Developers has partnered with Unity Buildwell to develop a 4 lakh square foot luxury retail center in West Delhi and both partners expect the project to generate annual rental income of at least Rs 100 crore.
SBI: State Bank of India (SBI) has yet to reimburse Rs.164 billion of the digital payment charges levied by Pradhan Mantri Jan Dhan Yojana (PMJDY) account holders for digital payments, a report said.
Laurus laboratories: The company acquired a significant minority stake in a CAR-T cell therapy company – Immunoadoptive Cell Therapy.